Status:
ACTIVE_NOT_RECRUITING
Prospective Treatment Algorithm Guiding Repair of Severe Ischemic Mitral Regurgitation
Lead Sponsor:
Ottawa Heart Institute Research Corporation
Conditions:
Mitral Regurgitation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Ischemic mitral regurgitation is a disease where the mitral valve is regurgitant, or leaking, as a result of changes in the muscle of the heart caused by coronary artery disease Ischemic mitral regurg...
Eligibility Criteria
Inclusion
- Severe ischemic mitral valve regurgitation
- 18 years of age, and able to provide informed consent.
Exclusion
- Mixed mitral valve pathology
- Acute ischemic mitral regurgitation
Key Trial Info
Start Date :
January 16 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2028
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT03292497
Start Date
January 16 2018
End Date
November 1 2028
Last Update
January 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Ottawa Heart Institute
Ottawa, Ontario, Canada, K1Y4W7